13941 completed, 4006 recruiting, 3895 unknown, 3133 terminated. 10432 Phase 2, 7230 Phase 1, 4002 Not applicable, 3287 Phase 3, 1116 Phase 4.
Follow Hemic and Lymphatic Diseases: new trials by email Literature Review of Hemic and Lymphatic Diseases trials Research Report on Hemic and Lymphatic Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| FLASH Pilot Phase 1 Safety Study IntraOp Mobetron UHDR, Linac - Cutaneous Lymphoma | Not applicable | Not yet recruiting | Lesley A. Jarvis | 10 | 2029-10-31 | 2026-11-16 |
| Sonrotoclax in Combination With Azacitidine for Previously Untreated Higher-risk Myelodysplastic Syndromes Each treatment cycle is 28-days. Azacitidine 75 mg/m² is administered subcutaneously or intravenously on Days 1-7 of each cycle. Sonrotoclax is orally administered once daily on Days 1-14 within each - MDS (Myelodysplastic Syndrome) | Phase 2 / Phase 3 | Not yet recruiting | The Affiliated People's Hospital of Ningbo University | 10 | 2028-09-01 | 2026-11-12 |
| A Study Evaluating Subcutaneous Versus Intravenous Blinatumomab in Newly Diagnosed Adults With B-cell Precursor Acute Lymphoblastic Leukaemia Blinatumomab, HyperCVAD - Philadelphia Chromosome Negative B-cell Precursor Acute Lymphoblastic Leukemia | Phase 3 | Not yet recruiting | Amgen | 560 | 2028-06-30 | 2026-09-15 |
| Safety and Efficacy of KL003 Cell Injection in Severe Sickle Cell Disease KL003 Cell Injection - Sickle Cell Disease | Not applicable | Suspended | Institute of Hematology & Blood Diseases Hospital, China | 3 | 2028-03-01 | 2026-11-05 |
| Pyronaridine in Acute Myeloid Leukemia (AML) Pyronaridine Tetraphosphate - Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL) | Phase 2 | Suspended | Armaceutica, Inc. | 200 | 2028-02-21 | 2026-10-19 |
| Effect of Ginger on Heavy Menstrual Bleeding in Women With Coagulation Disorders Ginger, Placebo - Women With Coagulation Disorders | Early Phase 1 | Not yet recruiting | University of Valladolid | 74 | 2028-02-01 | 2026-05-19 |
| MM-CARE: Cardiovascular Risk Assessment in Adults With Multiple Myeloma Oncology-Embedded Cardiovascular Risk Assessment Pathway, Primary Care Provider-Directed Cardiovascular Risk Assessment Pathway - Multiple Myeloma, Heart Disease Risk Factors | Not applicable | Not yet recruiting | University of Vermont Medical Center | 33 | 2028-02-01 | 2026-08-25 |
| Genetic Ablation of CD33 in HSC to Broaden the Therapeutic Index of CD33-directed Immunotherapy in Patients with AML Donor-derived CD34+ HSC with CRISPR/Cas9-mediated CD33 deletion, Gemtuzumab Ozogamicin - Relapsed/Refractory Acute Myeloid Leukemia (AML) | Phase 1 | Not yet recruiting | German Cancer Research Center | 12 | 2028-01-01 | 2025-03-14 |
| OPTIMAL LEAP: Optimizing Dihydroartemisinin-Piperaquine IPTsc Intervals to Advance Learning, Executive Function, Attendance, and Antimalarial Resistance Surveillance in Kenyan Schoolchildren Monthly DP, Quarterly DP - Malaria, Asymptomatic Malaria | Phase 3 | Not yet recruiting | Indiana University | 1500 | 2028-01-01 | 2026-09-01 |
| Methadone as an Alternative Treatment for Children Underdoing HSCT PCA plus methadone (Experimental), PCA Alone (SOC) - Leukemia, Aplastic Anemia | Phase 3 | Suspended | University of Texas Southwestern Medical Center | 60 | 2028-01-01 | 2025-10-23 |
| Prenatal Transplantation for Fetuses With Fanconi Anemia IUHSCT for FA-affected fetuses - Fanconi Anemia, Anemia, Hypoplastic, Congenital | Phase 1 / Phase 2 | Not yet recruiting | Agnieszka Czechowicz | 12 | 2028-01-01 | 2026-06-16 |
| A Phase 1 Open-Label, Dose-Ranging Safety and Pharmacokinetics Study of Oral Cladribine in Patients With Acute Myeloid Leukemia (AML) Cytarabine, Oral Cladribine - Acute Myeloid Leukemia (AML) | Phase 1 / Phase 2 | Not yet recruiting | M.D. Anderson Cancer Center | 58 | 2027-12-01 | 2026-08-25 |
| Study of YKST02 in Adults With Relapsed or Refractory Multiple Myeloma YKST02 - Relapsed or Refractory Multiple Myeloma (RRMM) | Phase 2 | Not yet recruiting | Excyte Biopharma Ltd | 64 | 2027-12-01 | 2026-11-06 |
| Study of NM8074 in Patients With aHUS With Evidence of Ongoing Thrombotic Microangiopathy NM8074 - aHUS - Atypical Hemolytic Uremic Syndrome | Phase 2 | Not yet recruiting | NovelMed Therapeutics | 12 | 2027-11-01 | 2026-04-13 |
| Self-administered Acupressure in Patients With Sickle Cell Disease Verum Acupressure (using AcuWand), Sham Acupressure (using AcuWand) - Sickle Cell Disease (SCD) | Not applicable | Not yet recruiting | University of Cincinnati | 300 | 2027-10-01 | 2026-10-15 |
| The Feasibility and Effects of Exercise on Patients Suffering From Multiple Myeloma Individual Exercise, Group Exercise - Multiple Myeloma | Not applicable | Suspended | Medical University of Vienna | 45 | 2027-09-01 | 2026-10-09 |
| Development of a Provider-Focused Intervention to Improve Health Outcomes in Pediatric Sickle Cell Disease Individuation and Perspective-Taking (IPT), pediatric SCD pain management education session - Sickle Cell Disease, Sickle Cell Anemia in Children | Not applicable | Not yet recruiting | Connecticut Children's Medical Center | 30 | 2027-09-01 | 2026-04-29 |
| Family-Focused Study to Support Medication for Opioid Use Disorder FamilyCHESS, Standard of Care - Opioid Use Disorder, Opioid Use Disorder, Moderate | Not applicable | Not yet recruiting | University of Wisconsin, Madison | 338 | 2027-08-31 | 2026-07-07 |
| Zanubrutinib and Sonrotoclax for the Treatment of Relapsed Chronic Lymphocytic Leukemia /Small Lymphocytic Leukemia, ZeuS-2 Trial Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | Phase 2 | Not yet recruiting | City of Hope Medical Center | 44 | 2027-08-04 | 2026-09-10 |
| Phase IIb Multicenter Randomized Controlled Trial Evaluating the Efficacy of Sivelestat in Patients With Septic Coagulopathy • Sivelestat intravenous infusion, NaCl intravenous infusion - Septic Shock, Coagulopathy | Phase 2 | Not yet recruiting | University Hospital, Strasbourg, France | 120 | 2027-08-01 | 2026-08-20 |
Showing 20 of 29601. Sign in to see all of them.
Multiple Myeloma (3675) · Leukemia, Myeloid, Acute (3594) · Lymphoma (3020) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (2524) · Leukemia (2382) · Lymphoma, Non-Hodgkin (2288) · Leukemia, Lymphocytic, Chronic, B-Cell (2019) · Myelodysplastic Syndromes (1970) · Lymphoma, Follicular (1876) · Lymphoma, Large B-Cell, Diffuse (1833) · Anemia (1670) · Hematologic Neoplasms (1449) · Recurrence (1438) · Hodgkin Disease (1302) · Lymphoma, Mantle-Cell (1212)
Hematologic Diseases (21722) · Neoplasms (18789) · Neoplasms by Histologic Type (18051) · Immune System Diseases (15912) · Lymphoproliferative Disorders (14178) · Immunoproliferative Disorders (14054) · Lymphatic Diseases (12750) · Pathological Conditions, Signs and Symptoms (7906) · Pathologic Processes (7192) · Leukemia (6421) · Hemorrhagic Disorders (6356) · Cardiovascular Diseases (5441) · Lymphoma (5295) · Vascular Diseases (5240)
Cyclophosphamide (1926) · Rituximab (1539) · Dexamethasone (1351) · Cytarabine (1141) · Lenalidomide (900) · fludarabine (862) · Vincristine (729) · Bortezomib (698) · Etoposide (689) · Doxorubicin (661) · Prednisone (657) · fludarabine phosphate (628) · venetoclax (628) · Azacitidine (611) · Methotrexate (588)
M.D. Anderson Cancer Center (840) · National Cancer Institute (NCI) (827) · Novartis Pharmaceuticals (416) · Memorial Sloan Kettering Cancer Center (353) · Hoffmann-La Roche (287) · Institute of Hematology & Blood Diseases Hospital, China (283) · Assistance Publique - Hôpitaux de Paris (279) · Fred Hutchinson Cancer Center (271) · Celgene (236) · Mayo Clinic (233) · National Heart, Lung, and Blood Institute (NHLBI) (225) · City of Hope Medical Center (220) · Pfizer (213) · GlaxoSmithKline (204) · St. Jude Children's Research Hospital (202)
United States (13843) · China (3767) · France (3154) · Italy (2421) · Germany (2210) · United Kingdom (2062) · Spain (1971) · Canada (1939) · Australia (1334) · South Korea (1069) · Belgium (1064) · Netherlands (1019) · Poland (974) · Japan (861) · Israel (797)
PMID 34515338, PMID 36005278, PMID 41671463, PMID 36791280, PMID 32499241, PMID 41114449, PMID 35622074, PMID 34932836, PMID 40135712, PMID 32632956, PMID 26965694, PMID 37975597, PMID 33783815, PMID 34398557, PMID 36240296, PMID 38780066, PMID 31401903, PMID 33394722, PMID 40550489, PMID 19005182, PMID 24383844, PMID 25527568, PMID 33242441, PMID 33357481, PMID 38502198, PMID 39319495, PMID 39563886, PMID 40750723, PMID 23524640, PMID 26373676, PMID 29674506, PMID 30957581, PMID 31221778, PMID 31375516, PMID 34724566, PMID 34922648, PMID 35235189, PMID 35244208, PMID 35829925, PMID 36064577, PMID 36184192, PMID 37022569, PMID 37192741, PMID 37254256, PMID 37505794, PMID 38620092, PMID 22689675, PMID 23065508, PMID 23620574, PMID 27209293
2023 (282), 2017 (151), 2016 (149), 2018 (144), 2015 (143), P30CA033572 (143), 2014 (140), 2019 (123), P30CA015704 (121), 2009 (101), 2025 (99), P30CA015083 (93), U10CA032102 (88), 2008 (74), P30CA016672 (73)